$21.850
-0.160 (-0.73%)收盘时
NRC 资讯
NRC 事件
Resideo Appoints Shane Harrison as CFO
Resideo Technologies (REZI) announced that Shane Harrison has been appointed as Resideo's CFO, effective September 1. He joins Resideo from NRC Health (NRC), a publicly traded healthcare technology and analytics company, where he served as CFO and was previously Senior Vice President of Finance and Investor Relations at PowerSchool, a leading K-12 education software provider.
NRC Health Introduces New AI Features to Enhance Healthcare Interactions
NRC Health announced an advancement introducing new AI capabilities designed to help healthcare leaders easily turn everyday human interactions into meaningful insight, action, and deeper connection, without sacrificing the human connection that care depends on. The company said, "NRC Health's latest innovation combines ambient listening with agentic AI to capture the sentiment, nuance, and intent of real-world conversations with a simple tap. AI then prepares ready-to-review documentation automatically, removing paperwork while preserving accuracy, context, and trust. Leaders stay fully present in the moment, while insight is captured and made actionable behind the scenes. Early deployments show that this approach is already capturing significantly richer, more complete documentation without increasing time spent in the interaction."
NRC Health Expands Partnership with Ann & Robert H. Lurie Children's Hospital
NRC Health announced that Ann & Robert H. Lurie Children's Hospital of Chicago has further expanded its partnership to include NRC Health's Reputation, alongside its continued use of NRC Health's Market Insights and Patient Experience solutions. "We are proud to expand our partnership with Lurie Children's as they continue to lead with a deep focus on the experiences of patients and families," said Helen Hrdy, Chief Operating Officer at NRC Health. "Their approach shows how leading organizations are bringing together patient experience, consumer insights, and digital reputation to strengthen trust and loyalty across every touchpoint."
NRC Health Authorizes Stock Repurchase Program Up to $60M
National Research Corporation, dba NRC Health, announced that its Board of Directors authorized a stock repurchase program of up to $60M of the company's outstanding common stock through March 31, 2028.
National Research Corporation TRCV Surpasses $152 Million
The company states: "National Research Corporation announced that it has surpassed $152 million in Total Recurring Contract Value - TRCV - as of March 4, 2026, representing an all-time high in the metric for NRC Health. TRCV represents the amount of revenue projected to be recognized over the next 12 months from renewable contracts and is calculated consistent with the definition previously disclosed in the company's periodic reports filed with the Securities and Exchange Commission."
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。


